Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Zanvastro
Published 2 months, 2 weeks ago
Description
Ionis wins FDA approval for Zanvastro, the first disease-modifying treatment for Alexander disease, Pharmaceutical Executive’s weekly biotech roundup gathers analyst reaction to the week's biggest stories, and Nate Hill of Strive Pharmacy talks through the regulatory uncertainty around compounded peptides.